4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-025537
President and CEO sold 70,000 shares at an average $15.15 ($1,060,701)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2022-04-21 | Sale | −25,000 | $15.24 | $380,948 | 1,290,763 | D |
| Walker Neal President and CEO | 2022-04-22 | Sale | −25,000 | $15.04 | $376,098 | 1,265,763 | D |
| Walker Neal President and CEO | 2022-04-25 | Sale | −20,000 | $15.18 | $303,656 | 1,245,763 | D |
| Open-market sales · 70,000 sh · avg $15.15 · $1,060,701 | |||||||
Loading xslF345X03/doc4.xml…